Gottesman Institute for Stem Cell and Regenerative Medicine Research, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
J Exp Med. 2013 Jul 1;210(7):1351-67. doi: 10.1084/jem.20122252. Epub 2013 Jun 17.
The intermediate filament protein Nestin labels populations of stem/progenitor cells, including self-renewing mesenchymal stem cells (MSCs), a major constituent of the hematopoietic stem cell (HSC) niche. However, the intracellular location of Nestin prevents its use for prospective live cell isolation. Hence it is important to find surface markers specific for Nestin⁺ cells. In this study, we show that the expression of PDGFRα and CD51 among CD45⁻ Ter119⁻ CD31⁻ mouse bone marrow (BM) stromal cells characterizes a large fraction of Nestin⁺ cells, containing most fibroblastic CFUs, mesenspheres, and self-renewal capacity after transplantation. The PDGFRα⁺ CD51 ⁺subset of Nestin⁺ cells is also enriched in major HSC maintenance genes, supporting the notion that niche activity co-segregates with MSC activity. Furthermore, we show that PDGFRα⁺ CD51⁺ cells in the human fetal BM represent a small subset of CD146⁺ cells expressing Nestin and enriched for MSC and HSC niche activities. Importantly, cultured human PDGFRα⁺ CD51⁺ nonadherent mesenspheres can significantly expand multipotent hematopoietic progenitors able to engraft immunodeficient mice. These results thus indicate that the HSC niche is conserved between the murine and human species and suggest that highly purified nonadherent cultures of niche cells may represent a useful novel technology to culture human hematopoietic stem and progenitor cells.
中间丝蛋白巢蛋白标记干细胞/祖细胞群体,包括自我更新的间充质干细胞(MSCs),是造血干细胞(HSC)龛的主要组成部分。然而,巢蛋白的细胞内位置使其无法用于前瞻性活细胞分离。因此,找到巢蛋白+细胞特异性的表面标志物非常重要。在这项研究中,我们表明,在 CD45⁻Ter119⁻CD31⁻小鼠骨髓(BM)基质细胞中,PDGFRα 和 CD51 的表达特征是巢蛋白+细胞的一个很大部分,其中包含大多数成纤维细胞集落形成单位、间质球体和移植后的自我更新能力。巢蛋白+细胞的 PDGFRα⁺CD51 ⁺亚群也富含主要的 HSC 维持基因,支持龛活性与 MSC 活性共分离的观点。此外,我们表明,人类胎儿 BM 中的 PDGFRα⁺CD51⁺细胞是表达巢蛋白的 CD146⁺细胞的一小部分,并且富含 MSC 和 HSC 龛活性。重要的是,培养的人类 PDGFRα⁺CD51⁺非贴壁间质球体可以显著扩增能够植入免疫缺陷小鼠的多能造血祖细胞。这些结果表明 HSC 龛在小鼠和人类之间是保守的,并表明高度纯化的龛细胞非贴壁培养物可能代表一种培养人类造血干细胞和祖细胞的有用新技术。